Agent Capital

Agent Capital

Agent Capital

Agent Capital is a biotech venture capital firm focused on investing in novel therapeutics that address unmet patient need. Our investment areas of focus are new products and technologies for oncology, immunology, neurology and rare disease indications.
Founded
2017
Follow us
Alexa global traffic share
Latest investments Show all
$45,000,000
Venture capital (Series C)
Palvella Therapeutics
$100,000,000
Venture capital (Series C)
Pliant Therapeutics
Team Size
2
Employees
Past year's investments

Agent Capital participated in fewer than 3 rounds over the past year

Latest rounds
  • Palvella Therapeutics: Venture capital (Series C) ($45M)
  • Pliant Therapeutics: Venture capital (Series C) ($100M)
  • Orchard Therapeutics: Venture capital (Series C) ($150M)